ImmuPharma plc (LSE:IMM) attracted attention after its shares were indicated +6.06% higher on 9 October 2026. The company sits within the healthcare space and is part of the FTSE AIM All-Share universe, except where noted otherwise. For smaller listed companies, a strong daily move …
The 4.05% advance has drawn attention to Genus as investors assess whether the move reflects a company-specific development, renewed interest in its sector, technical buying or a wider improvement in risk appetite. In the absence of a verified single catalyst, it would be premature …
Worldwide Healthcare Trust (LSE:WWH) has kept up an aggressive share buyback programme in recent weeks, repurchasing more than a million shares in a single session this week as it seeks to limit the discount at which its shares trade relative to net asset value. …
EKF Diagnostics Holdings plc (LSE:EKF) advanced +4.34% on 9 October 2026. The move places the share among the day's stronger performers in the UK small-cap market, including companies represented within the AIM market and the broader AIM All-Share Index. However, the daily percentage change …
Faron Pharmaceuticals Oy (LSE:FARN) advanced +4.11% on 9 October 2026. The move places the share among the day's stronger performers in the UK small-cap market, including companies represented within the AIM market and the broader AIM All-Share Index. However, the daily percentage change by …
GENinCode plc (LSE:GENI) advanced +4.00% on 9 October 2026. The move places the share among the day's stronger performers in the UK small-cap market, including companies represented within the AIM market and the broader AIM All-Share Index. However, the daily percentage change by itself …
Aptamer Group Plc (LSE:APTA) recorded a -5.75% move lower on 9 October 2026. That places the stock among the notable fallers in the session and raises the question of whether the move reflects company-specific news, a reassessment of its outlook, broader small-cap weakness or …
LSE:RENX declined 3.64% on 9 October 2026, placing Renalytix plc among the weaker shares in the displayed session.
Spire Healthcare (LSE:SPI), the FTSE 250 private hospital group, is moving through the final stages of aTakeoverprocess that began in May. The company remains in an offer period, and over recent days a large number of Takeover Code dealing disclosures have been filed by …
Syncona (LSE:SYNC), the FTSE 250 investor that founds and builds life sciences companies, has its most important clinical catalyst in years. On 21 September it said portfolio company Beacon Therapeutics had reported positive topline results from VISTA, a pivotal Phase II/III trial of the …